| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 97.85% | 96.83% | 98.61% | 97.65% | 98.45% | 97.98% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 2.15% | 3.17% | 1.39% | 2.35% | 1.55% | 2.02% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 6,56,076 | 122.19 | 12.09% | -0.33%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 84,936 | 73.74 | 7.30% | -0.01%↓ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 2,07,484 | 47.64 | 4.71% | -0.02%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 1,02,446 | 47.33 | 4.68% | -0.07%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 2,91,254 | 45.98 | 4.55% | 0.18%↑ |
| Ajanta Pharma Ltd. | Healthcare | 1,29,312 | 44.26 | 4.38% | 0.39%↑ |
| Mankind Pharma Ltd. | Healthcare | 1,55,574 | 39.6 | 3.92% | 0.03%↑ |
| Lupin Ltd. | Healthcare | 1,56,214 | 37.79 | 3.74% | 0.01%↑ |
| Sai Life Sciences Ltd. | Healthcare | 2,86,508 | 35.36 | 3.50% | 1.24%↑ |
| Abbott India Ltd. | Healthcare | 12,933 | 32.9 | 3.26% | -0.40%↓ |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1,77,757 | 32.64 | 3.23% | 0.06%↑ |
| Fortis Healthcare Ltd. | Healthcare | 3,39,011 | 32.44 | 3.21% | -0.10%↓ |
| Cipla Ltd. | Healthcare | 2,02,098 | 29.62 | 2.93% | -0.05%↓ |
| Ipca Laboratories Ltd. | Healthcare | 1,51,554 | 25.78 | 2.55% | 0.12%↑ |
| Gland Pharma Ltd. | Healthcare | 1,00,517 | 25.08 | 2.48% | 1.29%↑ |
| Shilpa Medicare Ltd. | Healthcare | 4,06,964 | 24.35 | 2.41% | -0.51%↓ |
| CORONA Remedies Ltd. | Healthcare | 1,16,970 | 23.01 | 2.28% | 0.21%↑ |
| Procter & Gamble Health Ltd. | Healthcare | 35,195 | 22.27 | 2.20% | -0.04%↓ |
| Alkem Laboratories Ltd. | Healthcare | 35,039 | 19.52 | 1.93% | -0.10%↓ |
| Thyrocare Technologies Ltd. | Healthcare | 3,54,579 | 19.48 | 1.93% | 0.04%↑ |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 96.06% | 95.17% | 96.91% | 96.02% | 96.50% | 95.80% |
| Services | 0.95% | 1.01% | 1.00% | 0.90% | 1.14% | 1.28% |
| Chemicals | 0.85% | 0.65% | 0.69% | 0.73% | 0.81% | 0.89% |
29.2 / 100
Weighted average Value score is 29.2. This indicates that portfolio is relatively reasonably valued using composite of value measures.
78.1 / 100
Weighted average Price Momentum score is 78.1. This indicates that portfolio has high momentum using composite of momentum measures.
89.3 / 100
Weighted average Quality score is 89.3. This indicates that portfolio has high quality using composite of quality measures.
78.5 / 100
Weighted average QVM score is 78.5. This indicates that portfolio has high QVM score and hence could be considered for investment.
